Biomaterials advancesMyocardial InfarctionAnimalsExtracellular MatrixVascular Endothelial Growth Factor AAngiopoietin-1
Bioactive cardiac ECM hydrogel sequentially released VEGF and Ang-1 mimic peptides to promote the recovery of myocardial infarction.
Siqi Song, Lu Yang, Kaiyan Su, Guoliang Wu, Ning Li, Junke Wang, Zhongxiang Yu, Chunying Shi
Published: 202610.1016/j.bioadv.2025.214617
Abstract
Vascular endothelial growth factor (VEGF) based therapeutic angiogenesis provided a promising treatment for myocardial infarction (MI). As a critical coordinated factor, angiopoietin-1 (Ang-1) and its mimic peptide (AMP) were revealed to promote VEGF…
Preview only. Read the full abstract at the source